Literature DB >> 27507103

IBD: A timely diagnosis of primary sclerosing cholangitis in IBD.

Bo Shen1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27507103     DOI： 10.1038/nrgastro.2016.130

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

Authors:  Stuart R Cairns; John H Scholefield; Robert J Steele; Malcolm G Dunlop; Huw J W Thomas; Gareth D Evans; Jayne A Eaden; Matthew D Rutter; Wendy P Atkin; Brian P Saunders; Anneke Lucassen; Paul Jenkins; Peter D Fairclough; Christopher R J Woodhouse
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

2.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

Authors: 
Journal:  J Hepatol       Date:  2009-06-06       Impact factor: 25.083

3.  European evidence based consensus for endoscopy in inflammatory bowel disease.

Authors:  Vito Annese; Marco Daperno; Matthew D Rutter; Aurelien Amiot; Peter Bossuyt; James East; Marc Ferrante; Martin Götz; Konstantinos H Katsanos; Ralf Kießlich; Ingrid Ordás; Alessandro Repici; Bruno Rosa; Shaji Sebastian; Torsten Kucharzik; Rami Eliakim
Journal:  J Crohns Colitis       Date:  2013-11-01       Impact factor: 9.071

4.  Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2010-01-12       Impact factor: 10.864

5.  AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Authors:  Francis A Farraye; Robert D Odze; Jayne Eaden; Steven H Itzkowitz; Robert P McCabe; Themistocles Dassopoulos; James D Lewis; Thomas A Ullman; Tom James; Robin McLeod; Lawrence J Burgart; John Allen; Joel V Brill
Journal:  Gastroenterology       Date:  2010-02       Impact factor: 22.682

6.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  E V Loftus; G C Harewood; C G Loftus; W J Tremaine; W S Harmsen; A R Zinsmeister; D A Jewell; W J Sandborn
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

7.  ACG Clinical Guideline: Primary Sclerosing Cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; M Edwyn Harrison
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

Review 8.  Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

9.  Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.

Authors:  Aida Kapic Lunder; Johannes Roksund Hov; Arne Borthne; Jostein Gleditsch; Glenn Johannesen; Knut Tveit; Ellen Viktil; Magne Henriksen; Øistein Hovde; Gert Huppertz-Hauss; Ole Høie; Marte Lie Høivik; Iril Monstad; Inger Camilla Solberg; Jørgen Jahnsen; Tom Hemming Karlsen; Bjørn Moum; Morten Vatn; Anne Negård
Journal:  Gastroenterology       Date:  2016-06-21       Impact factor: 22.682

10.  Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.

Authors:  Roy M Soetikno; Otto S Lin; Paul A Heidenreich; Harvey S Young; Michael O Blackstone
Journal:  Gastrointest Endosc       Date:  2002-07       Impact factor: 9.427
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.